To the top

Page Manager: Webmaster
Last update: 4/19/2017 1:56 PM

Tell a friend about this page
Print version

Pierre Åman - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Pierre Åman

Professor

Pierre Åman
Professor
pierre.aman@llcr.med.gu.se
+46 31 786 6732
0706-846085

Postal Address: Box 425, 40530 Göteborg
Visiting Address: Medicinaregata 1F , 41390 Göteborg


Department of Laboratory Medicine at Institute of Biomedicine (More Information)
Sahlgrenska universitetssjukhuset
413 45 Göteborg
Visiting Address: Gula stråket 8 , 413 45 Göteborg

Latest publications

FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex
Malin Lindén, Christer Thomsen, Pernilla Grundevik, Emma Jonasson, Daniel Andersson et al.
EMBO Reports, Journal article 2019
Journal article

JAK–STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma
Soheila Dolatabadi, Emma Jonasson, Malin Lindén, Bentolhoda Fereydouni, Karin Bäcksten et al.
International Journal of Cancer, Journal article 2019
Journal article

Requirement for YAP1 signaling in myxoid liposarcoma.
Marcel Trautmann, Ya-Yun Cheng, Patrizia Jensen, Ninel Azoitei, Ines Brunner et al.
EMBO molecular medicine, Journal article 2019
Journal article

Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma
M. Trautmann, M. Cyra, I. Isfort, B. Jeiler, A. Kruger et al.
Molecular Cancer Therapeutics, Journal article 2019
Journal article

Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses.
David Svec, Soheila Dolatabadi, Christer Thomsen, Nicole Cordes, Mark Shannon et al.
Laboratory investigation; a journal of technical methods and pathology, Journal article 2018
Journal article

FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma
M. Trautmann, J. Menzel, C. Bertling, M. Cyra, I. Isfort et al.
Clinical Cancer Research, Journal article 2017
Journal article

HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.
Michaela Angelika Ihle, Sabine Merkelbach-Bruse, Wolfgang Hartmann, Sebastian Bauer, Nancy Ratner et al.
The journal of pathology. Clinical research, Journal article 2016
Journal article

Showing 31 - 40 of 53

2009

2008

2007

Tissue and cell specific expression patterns of the proto-oncogenic FUS, EWS and TAF15 ribonucleoproteins
Mattias K Andersson, Yvonne Arvidsson, Anita Olofsson, Göran Stenman, Ola Nilsson et al.
Molecular Targets for Cancer, Whistler Resort, Whistler, British Columbia, Canada, Poster 2007
Poster

TET family proteins localize to stress granules upon abnormal protein expression
Mattias K Andersson, Pierre Åman
Protein Synthesis and Translational Control, EMBL, Heidelberg, Germany, Poster 2007
Poster

Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology.
Katarina Engström, Peter Bergh, C. G. Cederlund, Ragnar Hultborn, Helena Willen et al.
Acta oncologica (Stockholm, Sweden), Journal article 2007
Journal article

2006

2005

Showing 31 - 40 of 53

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://gu.se/english/about_the_university/staff/?publicationPageNumber=4&selectedTab=2&languageId=100001&userId=xamapi
Utskriftsdatum: 2019-11-14